Diabetes Dialogue: April 2022
- Author
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
- Published
- Thu 28 Apr 2022
- Episode Link
- https://audioboom.com/posts/8073965
In the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini discuss the implications of semaglutide 2.0 mg (Ozempic)'s approval, the use of novel glycemic control metrics, and a preview of ATTD 2022.
